Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Serum Oxidative Status as a Potential Predictor of Coronary Artery Disease.

NCT03646019 is registered in ClinicalTrials.gov with Prof. Tony hayek MD as lead sponsor.

NCT NCT03646019
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03646019 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Serum Oxidative Status as a Potential Predictor of Coronary Artery Disease.
Lead sponsor
Prof. Tony hayek MD
Phase
Observational
Overall status
Unknown status
Start date
September 30, 2018
Completion date
March 31, 2019
Enrollment
200 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease, paraoxanase 1, thiobarbituric acid reactive substances, thiol groups